- Home
- NEXT vs OCUL Comparison
NEXT vs OCUL Comparison
Compare NEXT & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEXT
- OCUL
- Stock Information
- Founded
- NEXT 2010
- OCUL 2006
- Country
- NEXT United States
- OCUL United States
- Employees
- NEXT N/A
- OCUL N/A
- Industry
- NEXT Oil & Gas Production
- OCUL Biotechnology: Pharmaceutical Preparations
- Sector
- NEXT Energy
- OCUL Health Care
- Exchange
- NEXT Nasdaq
- OCUL Nasdaq
- Market Cap
- NEXT 2.0B
- OCUL 1.8B
- IPO Year
- NEXT N/A
- OCUL 2014
- Fundamental
- Price
- NEXT $11.24
- OCUL $11.96
- Analyst Decision
- NEXT Buy
- OCUL Strong Buy
- Analyst Count
- NEXT 1
- OCUL 7
- Target Price
- NEXT $15.00
- OCUL $17.33
- AVG Volume (30 Days)
- NEXT 3.2M
- OCUL 2.3M
- Earning Date
- NEXT 08-13-2025
- OCUL 08-06-2025
- Dividend Yield
- NEXT N/A
- OCUL N/A
- EPS Growth
- NEXT N/A
- OCUL N/A
- EPS
- NEXT N/A
- OCUL N/A
- Revenue
- NEXT N/A
- OCUL $59,647,000.00
- Revenue This Year
- NEXT N/A
- OCUL N/A
- Revenue Next Year
- NEXT N/A
- OCUL $20.85
- P/E Ratio
- NEXT N/A
- OCUL N/A
- Revenue Growth
- NEXT N/A
- OCUL N/A
- 52 Week Low
- NEXT $4.27
- OCUL $5.79
- 52 Week High
- NEXT $12.12
- OCUL $11.96
- Technical
- Relative Strength Index (RSI)
- NEXT 67.04
- OCUL 80.08
- Support Level
- NEXT $8.89
- OCUL $11.23
- Resistance Level
- NEXT $12.12
- OCUL $11.47
- Average True Range (ATR)
- NEXT 0.52
- OCUL 0.44
- MACD
- NEXT 0.10
- OCUL 0.08
- Stochastic Oscillator
- NEXT 72.76
- OCUL 100.00
About NEXT NextDecade Corporation
NextDecade Corp is a Houston-based energy company engaged in construction and development activities related to the liquefaction of natural gas and sale of LNG and the capture and storage of CO2 emissions. The group is constructing and developing a natural gas liquefaction and export facility located in the Rio Grande Valley near Brownsville, Texas (the Rio Grande LNG Facility). It also engaged in NEXT Carbon Solutions advancing proprietary processes to lower the cost of utilizing carbon capture and storage (CCS) and help companies reduce their emissions and achieve their clean energy goals.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.